Translational population science
Exploiting new genetic and epigenetic technologies
We use this data to work out which factors might help prevent illness, which treatments are most effective, and to predict how a disease might affect an individual.
Using biological markers to study health and disease
Processing, governance and management of biosamples
Application of Mendelian randomization techniques
Research case studies
Finding blood-based biomarkers to help diagnose lung cancer earlier.
Drug design using genetic information.
Informing alcohol policy using evidence driven methods.
Get in touch
- George Davey Smith
- 0117 331 0095
- Hazel Phillips
- 0117 331 0072
Latest research news
New population-wide health data resource to accelerate research on COVID-19 and cardiovascular disease in England
For the first time, a new linked health data resource covering 54.4 million people – ...
NIHR Bristol BRC to benefit from internship programme to tackle underrepresentation of Black people in science
The National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC), a partnership ...